MediciNova, Inc.
Records under this name other than the patents MediciNova, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 32 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,338,453 | Treatment of Progressive Neurodegenerative Disease with Ibudilast No holder on record In force · High confidence | In force | High confidence | |
| US 7,534,806 | Method for Treating Neuropathic Pain and Associated Syndromes Term ended Term ended Dec 6, 2025 · High confidence | Term ended | Term ended Dec 6, 2025 | High confidence |
| US 7,429,617 | Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitis Term ended Term ended Sep 30, 2025 · USPTO record | Term ended | Term ended Sep 30, 2025 | USPTO record |
| US 7,786,169 | Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis Term ended Term ended Apr 27, 2025 · USPTO record | Term ended | Term ended Apr 27, 2025 | USPTO record |
| US 8,026,282 | Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome Term ended Term ended Apr 27, 2025 · USPTO record | Term ended | Term ended Apr 27, 2025 | USPTO record |
| US 7,060,854 | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid Term ended Term ended Jun 24, 2023 · USPTO record | Term ended | Term ended Jun 24, 2023 | USPTO record |
| US 7,064,146 | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use Term ended Term ended Jun 24, 2023 · USPTO record | Term ended | Term ended Jun 24, 2023 | USPTO record |
| US 7,153,993 | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid Term ended Ended no later than Jun 24, 2023 · USPTO record | Term ended | Ended no later than Jun 24, 2023 | USPTO record |
| US 7,365,224 | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use Term ended Ended no later than Jun 24, 2023 · USPTO record | Term ended | Ended no later than Jun 24, 2023 | USPTO record |
| US 7,728,169 | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use Term ended Ended no later than Jun 24, 2023 · USPTO record | Term ended | Ended no later than Jun 24, 2023 | USPTO record |